Home > Insider Trading > Filing (0001209191-19-015276)

Filing Details

Accession Number:: 0001209191-19-015276
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-03-01 20:19:06
Reporting Period:: 2019-02-28

Accepted Time:: 2019-03-01 20:19:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
897448	Amarin Corp Plc	AMRN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1289884	B Steven Ketchum	C/O Amarin Pharma, Inc. 1430 Route 206 Bedminster NJ 07921	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2019-02-28	2,605	$1.40	357,097	No	4	M	Direct
Ordinary Shares	Acquisiton	2019-02-28	4,167	$2.50	361,264	No	4	M	Direct
Ordinary Shares	Acquisiton	2019-02-28	2,771	$2.95	364,035	No	4	M	Direct
Ordinary Shares	Disposition	2019-02-28	9,543	$20.67	354,492	No	4	S	Direct
Ordinary Shares	Acquisiton	2019-03-01	46,000	$2.50	400,492	No	4	M	Direct
Ordinary Shares	Disposition	2019-03-01	3,503	$20.94	396,989	No	4	S	Direct
Ordinary Shares	Disposition	2019-03-01	35,398	$22.10	361,591	No	4	S	Direct
Ordinary Shares	Disposition	2019-03-01	7,099	$22.64	354,492	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2019-02-28	2,605	$0.00	2,605	$1.40
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2019-02-28	4,167	$0.00	4,167	$2.50
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2019-02-28	2,771	$0.00	2,771	$2.95
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2019-03-01	46,000	$0.00	46,000	$2.50

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,645	2026-01-31	No	4	M	Direct
16,664	2025-07-06	No	4	M	Direct
64,229	2027-01-31	No	4	M	Direct
194,000	2025-07-06	No	4	M	Direct

Footnotes

The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Please see the section titled "Remarks" below for additional information.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.42 to $21.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.50 to $21.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.50 to $22.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.50 to $22.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016.
On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015.
On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017.
On July 6, 2015, the Reporting Person was granted an option to purchase 240,000 Ordinary shares under the Plan. The vesting of the shares was subject to certain performance milestone that was previously achieved. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015.